chr2-166056450-A-G

Variant summary

Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong

The NM_001165963.4(SCN1A):​c.434T>C​(p.Met145Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M145R) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SCN1A
NM_001165963.4 missense

Scores

17
1
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3O:1

Conservation

PhyloP100: 9.23

Publications

19 publications found
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 17 ACMG points.

PM1
In a hotspot region, there are 8 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 10 uncertain in NM_001165963.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-166056450-A-C is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 1065179.Status of the report is criteria_provided_single_submitter, 1 stars.
PP2
Missense variant in the SCN1A gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 848 curated pathogenic missense variants (we use a threshold of 10). The gene has 89 curated benign missense variants. Gene score misZ: 5.2206 (above the threshold of 3.09). Trascript score misZ: 7.6022 (above the threshold of 3.09). GenCC associations: The gene is linked to familial or sporadic hemiplegic migraine, myoclonic-astatic epilepsy, arthrogryposis, Dravet syndrome, malignant migrating partial seizures of infancy, generalized epilepsy with febrile seizures plus, type 2, migraine, familial hemiplegic, 3, developmental and epileptic encephalopathy, 6A, familial hemiplegic migraine, generalized epilepsy with febrile seizures plus, genetic developmental and epileptic encephalopathy, Lennox-Gastaut syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.925
PP5
Variant 2-166056450-A-G is Pathogenic according to our data. Variant chr2-166056450-A-G is described in ClinVar as Pathogenic. ClinVar VariationId is 12896.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN1ANM_001165963.4 linkc.434T>C p.Met145Thr missense_variant Exon 6 of 29 ENST00000674923.1 NP_001159435.1 P35498-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN1AENST00000674923.1 linkc.434T>C p.Met145Thr missense_variant Exon 6 of 29 NM_001165963.4 ENSP00000501589.1 P35498-1
SCN1AENST00000303395.9 linkc.434T>C p.Met145Thr missense_variant Exon 5 of 28 5 ENSP00000303540.4 P35498-1
SCN1AENST00000375405.7 linkc.434T>C p.Met145Thr missense_variant Exon 3 of 26 5 ENSP00000364554.3 P35498-2
SCN1AENST00000409050.2 linkc.434T>C p.Met145Thr missense_variant Exon 5 of 28 5 ENSP00000386312.1 P35498-3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1456296
Hom.:
0
Cov.:
28
AF XY:
0.00
AC XY:
0
AN XY:
724914
African (AFR)
AF:
0.00
AC:
0
AN:
33314
American (AMR)
AF:
0.00
AC:
0
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26070
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39612
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86130
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5752
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1107112
Other (OTH)
AF:
0.00
AC:
0
AN:
60196
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
EpiCase
AF:
0.0000546
EpiControl
AF:
0.00

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Severe myoclonic epilepsy in infancy;C1858673:Generalized epilepsy with febrile seizures plus, type 2;C1864987:Migraine, familial hemiplegic, 3;C5543353:Developmental and epileptic encephalopathy 6B Pathogenic:1
Feb 02, 2024
Institute of Immunology and Genetics Kaiserslautern
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACMG Criteria: PM1,PM2_P,PM5,PS3,PP3,PP5 ; Variant was found in heterozygous state -

not provided Pathogenic:1
Jun 08, 2016
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The M145T missense variant in the SCN1A gene has been reported previously to co-segregate with febrile seizures in a large family, and functional studies demonstrated abnormalities consistent with a loss-of-function pathogenic variant (Mantegazza et al., 2005; Colosimo et al., 2007). The M145T variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The M145T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, this substitution alters a highly conserved position predicted to be within the transmembrane segment S1 of the first homologous domain, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, a missense variant at the same position (M145V) has been reported in the Human Gene Mutation Database in association with Dravet syndrome (Stenson et al., 2014). -

Febrile seizures, familial, 3a Pathogenic:1
Dec 13, 2005
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Generalized epilepsy with febrile seizures plus, type 2 Other:1
-
UniProtKB/Swiss-Prot
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.57
D
BayesDel_noAF
Pathogenic
0.58
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.99
.;.;.;D;.;.;D;.;.;.
Eigen
Pathogenic
0.97
Eigen_PC
Pathogenic
0.91
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.97
D;D;D;D;.;D;.;.;D;D
M_CAP
Pathogenic
0.95
D
MetaRNN
Pathogenic
0.92
D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.7
.;.;.;H;H;.;H;H;H;H
PhyloP100
9.2
PrimateAI
Pathogenic
0.89
D
PROVEAN
Pathogenic
-5.5
.;.;.;D;.;.;D;.;D;D
REVEL
Pathogenic
0.96
Sift
Pathogenic
0.0
.;.;.;D;.;.;D;.;D;D
Sift4G
Pathogenic
0.0
.;.;.;D;.;.;D;.;D;D
Polyphen
0.97, 1.0
.;.;.;D;D;.;D;D;D;.
Vest4
0.91, 0.97, 0.90, 0.96
MutPred
0.65
Loss of catalytic residue at M147 (P = 0.0269);Loss of catalytic residue at M147 (P = 0.0269);Loss of catalytic residue at M147 (P = 0.0269);Loss of catalytic residue at M147 (P = 0.0269);Loss of catalytic residue at M147 (P = 0.0269);Loss of catalytic residue at M147 (P = 0.0269);Loss of catalytic residue at M147 (P = 0.0269);Loss of catalytic residue at M147 (P = 0.0269);Loss of catalytic residue at M147 (P = 0.0269);Loss of catalytic residue at M147 (P = 0.0269);
MVP
0.98
MPC
0.78
ClinPred
0.99
D
GERP RS
5.7
Varity_R
0.91
gMVP
0.99
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.19
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121918631; hg19: chr2-166912960; API